Spots Global Cancer Trial Database for nsclc expansion cohort: regorafenib 100 mg
Every month we try and update this database with for nsclc expansion cohort: regorafenib 100 mg cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Continuous Dosing of BAY73-4506 in Patients With Advanced Malignancies | NCT01117623 | Neoplasm | Escalation coho... Escalation coho... Escalation coho... Escalation coho... Escalation coho... HCC Child-Pugh ... HCC Child-Pugh ... NSCLC expansion... | 18 Years - | Bayer | |
Continuous Dosing of BAY73-4506 in Patients With Advanced Malignancies | NCT01117623 | Neoplasm | Escalation coho... Escalation coho... Escalation coho... Escalation coho... Escalation coho... HCC Child-Pugh ... HCC Child-Pugh ... NSCLC expansion... | 18 Years - | Bayer |